[event timezone=“Pacific/Auckland” start=“2022-05-12 13:00” status=“public” name=“Covid Accelerating Technology” url=“https://www.eventbrite.co.nz/e/covid-accelerating-technology-tickets-313132095527?aff=ebdsoporgprofile” end=“2022-05-12 15:00” allowedGroups=“trust_level_0”]
[/event]
Connecting Australia and New Zealand’s innovation ecosystems to talk about how Covid-19 has impacted technology development.
Covid-19 has been the topic of focus worldwide for the past 2 years, with the pandemic having an effect on almost every aspect of life. As no surprise, the delivery and organisation of healthcare services has had to respond and adapt with this ever developing situation to ensure patients are still receiving the care they require; and technology has been a key player. We are fortunate to have Assoc. Prof. Deepak Bhonagiri talk about his developments of a virtual intensive care unit (teleICU) and how the COVID 19 pandemic provided a great use case example of when such a technology is needed.
This space is continuing to evolve as we understand more about long-covid and future pandemic management with Prof. David Lynn and Prof. Chris Pemberton on the forfront of emerging research.
This workshop brings together the three key experts exploring Covid-19, the potential long term effects and the technologies assisting healthcare during this pandemic and for the future.
Join us for this free, virtual workshop with speakers from across New Zealand and Australia who will share the innovations and research being conducted across our ecosystems. Our panel will discuss what they have learnt and what research is telling so far as a result of the Covid-19 pandemic. Following these talks, we will have a Q&A session to answer some of your questions.
Workshop presenters
Australia
-
Associate Professor Deepak Bhonagiri - Assoc Prof Deepak Bhonagiri is the Co-Chair of the Virtual Care working Group in SWSLHD and received a COVID 19 Office of Health and Medical Research NSW grant to evaluate 24/7 eICU – a teleICU project to support rural ICUs during COVID 19. In addition to routine ICU monitoring he is also conducting a phase 1 trial of wireless remote monitoring using wearable devices and AI algorithms to detect clinical deterioration in hospital patients. He will discuss the design and implementation of a control centre to coordinate and respond to deterioration of remote monitored patient that is part of his redeveloped ICU opening in July 2022 .
-
Professor David Lynn - Prof. Lynn will present his team’s recent work showing that long-term dysregulation of the immune system occurs in convalescent individuals recovering from COVID19 and will discuss how this dysregulation may be linked to symptoms of long COVID. See Ryan et al BMC Medicine 2022.
New Zealand
- Professor Chris Pemberton - Key ongoing aspects of the COVID pandemic include: how long do antibody responses to COVID infection versus vaccination last? How do vaccination and COVID infection affect cardiac markers and others markers relevant to heart health? This talk will cover emerging results from the Christchurch Heart Institute hosted CANTATA study which seeks to answer some these questions in order to help inform ongoing health management strategies related to COVID and also establish NZ based antibody and marker assays that can be used in the future for COVID and related respiratory infection studies.